Kymera Therapeutics, Inc. (KYMR)
77.97
-1.60
(-2.01%)
USD |
NASDAQ |
Mar 20, 16:00
77.97
0.00 (0.00%)
After-Hours: 20:00
Kymera Therapeutics Total Liabilities (Quarterly) : 163.15M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 777.09M |
| Gilead Sciences, Inc. | 36.40B |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Kodiak Sciences, Inc. | 194.38M |
| Structure Therapeutics, Inc. | 67.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.743B |
| Shareholders Equity (Quarterly) | 1.580B |
| Debt to Equity Ratio | 0.0521 |
| Current Ratio | 10.47 |
| Net Debt Paydown Yield | 0.02% |